Pegah Ebrahimi - 29 Aug 2025 Form 4 Insider Report for Enovix Corp (ENVX)

Role
Director
Signature
/s/ Arthi Chakravarthy, Attorney-in-Fact for Pegah Ebrahimi
Issuer symbol
ENVX
Transactions as of
29 Aug 2025
Transactions value $
$55,116
Form type
4
Filing time
02 Sep 2025, 21:54:12 UTC
Previous filing
13 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ebrahimi Pegah Director C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT /s/ Arthi Chakravarthy, Attorney-in-Fact for Pegah Ebrahimi 02 Sep 2025 0001892064

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENVX Common Stock Exercise of in-the-money or at-the-money derivative security $55,116 +6,299 +9.45% $8.75 72,939 29 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENVX Warrant (Right to Buy) Exercise of in-the-money or at-the-money derivative security $0 -6,299 -100% $0 0 29 Aug 2025 Common Stock, par value $0.0001 6,299 $8.75 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares issued upon the exercise of publicly-traded warrants (the "Warrants") by the Reporting Person. The Warrants were distributed by the Issuer on July 21, 2025, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement").
F2 Includes 22,543 shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3 In accordance with the Warrant Agreement, the original expiration date ceased to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the Expiration Date), subject to automatic acceleration upon satisfaction of the early expiration price condition. On August 28, 2025, the early expiration price condition was met and the expiration date for the warrants was accelerated to be on August 29, 2025. The Warrants was ceased to be exercisable prior to 5:00pm New York City time on August 29, 2025.